Legend Biotech (LEGN) Receivables: 2019-2025
Historic Receivables for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to $2.4 million.
- Legend Biotech's Receivables fell 7.90% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.4 million, marking a year-over-year decrease of 67.88%. This contributed to the annual value of $7.1 million for FY2024, which is 92.99% down from last year.
- According to the latest figures from Q3 2025, Legend Biotech's Receivables is $2.4 million, which was down 91.61% from $28.6 million recorded in Q2 2025.
- Legend Biotech's 5-year Receivables high stood at $100.8 million for Q4 2023, and its period low was $56,000 during Q1 2023.
- Over the past 3 years, Legend Biotech's median Receivables value was $7.1 million (recorded in 2024), while the average stood at $24.8 million.
- Data for Legend Biotech's Receivables shows a peak YoY increase of 9,613.97% (in 2023) and a maximum YoY decrease of 99.89% (in 2023) over the last 5 years.
- Quarterly analysis of 5 years shows Legend Biotech's Receivables stood at $100.4 million in 2021, then slumped by 98.97% to $1.0 million in 2022, then spiked by 9,613.97% to $100.8 million in 2023, then tumbled by 92.99% to $7.1 million in 2024, then dropped by 7.90% to $2.4 million in 2025.
- Its last three reported values are $2.4 million in Q3 2025, $28.6 million for Q2 2025, and $1.3 million during Q1 2025.